Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cue Biopharma (CUE) Preferred Shares (2018 - 2019)

Historic Preferred Shares for Cue Biopharma (CUE) over the last 2 years, with Q4 2019 value amounting to $163.1 million.

  • Cue Biopharma's Preferred Shares rose 5418.24% to $163.1 million in Q4 2019 from the same period last year, while for Dec 2019 it was $163.1 million, marking a year-over-year increase of 5418.24%. This contributed to the annual value of $163.1 million for FY2019, which is 5418.24% up from last year.
  • Cue Biopharma's Preferred Shares amounted to $163.1 million in Q4 2019, which was up 5418.24% from $105.8 million recorded in Q4 2018.
  • Cue Biopharma's Preferred Shares' 5-year high stood at $163.1 million during Q4 2019, with a 5-year trough of $105.8 million in Q4 2018.